Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
12,363 total articles
Rubrik delivered a clean beat and raised fiscal 2027 guidance, the Sophos partnership expands GTM reach, and technical momentum plus falling short interest create a favorable trade setup for a mid-term (45 trading days) long. Valuation is rich, so keep risk tight and size accordingly.
Nano Labs is a modest-cap Chinese fabless chip designer trading at a $41.1M market cap with a PE of 1.97 and PB of 0.40. Recent partnership talks around North American AI data centers and ongoing product launches keep AI-demand narrative intact. Given cheap valuation, insider buying and mixed technicals, we favor a tactical buy for swing traders wh…
Trimble ($53.74) has quietly shifted from a hardware-led company to a software-and-services business (roughly 72% software by revenue in some coverage). The market still trades it with the story of the old Trimble: cyclical hardware, lumpy bookings, and low growth. Fundamentals - $12.53B market cap, $480.5M trailing free cash flow, EV/EBITDA ~15.7,…
Meta Platforms is a buy into its AI-led reacceleration. The stock trades at ~22x earnings and ~12x cash flow while generating $48.3B in FCF and holding a conservative balance sheet. Product momentum (Muse Image rollout) and a potential compute-rental market offer upside catalysts. Trade plan: enter at $615.58, stop at $560.00, target $750.00, horiz…
Ovid (OVID) has rerated strongly this year, but a closer look at enterprise value, recent financing, and clinical readouts suggests the market still underprices the company’s next-stage assets. With positive Phase 1 data for OV329, a $60M PIPE, and roughly $120M of implied net cash on the balance sheet, Ovid presents a high-risk, high-reward long t…
Zoom is no longer just a video platform. Its strategic stake in Anthropic and early AI integrations create a path to higher ARPU, stickier enterprise contracts, and new platform revenue. The market is underestimating the optionality here. We upgrade to a buy and lay out an actionable trade: enter at $75.00, target $105.00, stop $60.00, horizon long…
Sterling Infrastructure (STRL) remains a high-conviction long idea after a powerful run fueled by AI data-center buildout and strategic acquisitions. Strong Q1 results, a $5.15B backlog and raised guidance support upside toward $900 over the next 180 trading days, but rich multiples and technical pullbacks demand disciplined sizing and a tight stop…
Carriage Services is a cash-generative funeral and cemetery operator trading at a reasonable multiple, carrying leverage but delivering free cash flow and a rising footprint. This trade targets a bounce toward prior resistance near the 52-week high, with a tight stop to limit downside while giving the business time to convert acquisitions and opera…
Visa is a business built on durable network effects, exceptional returns on equity and predictable free cash flow. The stock looks like a compounder that’s quietly re-rating as tokenisation, stablecoin consortium activity, and cross-border volume recovery provide upside. This is an actionable long: enter at $350.00, stop $330.00, target $400.00 ove…
<p>Ring Energy (REI) just improved its liquidity and cut debt, handing investors a window to take a disciplined long swing trade. The company still trades cheaply by several measures, free cash flow is meaningful relative to market cap, and technicals are stabilizing. This idea lays out an entry, stop, and target for a mid-term trade (45 trading da…
Cognex (CGNX) sells critical machine vision systems into manufacturing and logistics. The stock has pulled back from its late-June highs and offers a tradeable entry around $64.21. The business generates steady free cash flow, carries no debt, and sits squarely in a growing market; those fundamentals support a mid-term long trade toward $75, while …
CoreWeave (CRWV) has been punished this week after Meta signaled plans to monetize excess GPU capacity. The headlines ignore that CoreWeave has grown revenue rapidly, keeps strategic GPU partnerships, and is trading with technically oversold readings and heavy short interest. This idea argues the hyperscaler risk is overblown and lays out a clear e…
Ovid Therapeutics (OVID) reported clean Phase 1 safety data for OV329 and secured a $60M PIPE to push Phase 2 development and expand into tuberous sclerosis complex (TSC) and infantile spasms (IS). The combination of binary clinical catalysts, an improved safety profile vs older GABA-aminotransferase inhibitors, and roughly $120M of implied net cas…
Oracle is trading well below its recent peak despite 17% revenue growth and a booming cloud-infrastructure business. The stock is oversold technically and priced for execution failure: that combination creates a tradeable long with defined risk and asymmetric upside if AI demand and backlog convert as management forecasts.
Berkshire Hathaway (BRK.B) is an attractive tactical long after recent consolidation around $500. With a $1.09T market cap, P/E ~15, nearly $400B of investable cash, and bullish technicals, we upgrade to a buy and lay out a clear entry at $505.00, a stop at $485.00 and a target of $540.00 over a mid-term 45 trading day horizon.
<p>NIO reported a June delivery beat (40,597 units, +62.9% YoY) and meaningful margin improvement (vehicle margins 18.8% in Q1 2026). At a market cap of ~$11.9B and a share price around $4.90, the stock looks positioned for multiple re-ratings if delivery and margin trends persist. This trade plan offers an entry, stop and target tied to those oper…
Newmont (NEM) sold off sharply in June alongside a rout in gold, but the company’s scale, strong margins, $9.24B free cash flow and recently-expanded buyback make a tactical long appealing. This is a mid-term swing trade: enter on weakness, limit downside with a tight stop, and target a recovery back toward the 50-day and mid-cycle levels if gold s…
TTM Technologies is a direct beneficiary of the AI/data-center build cycle and just reported a step-up in sales and margins. With a market cap near $15B, a manageable balance sheet, and valuation that still prices high-growth expectations, TTMI presents a mid-term swing opportunity. This trade plan outlines an entry at $144.00, stop at $135.00 and …
Nano Labs (NA) is a small-cap fabless chip designer trading at a $41.2M market cap, ultra-low valuation (P/E ~1.97, P/B ~0.40) and elevated short interest. Recent corporate moves — a MoU to explore North American AI data center infrastructure, CEO open-market buying and product launches — give a playbook for a speculative long swing. This trade ide…
Sprouts Farmers Market is a compelling buy after recent weakness. The grocer combines strong gross margins, attractive per-store profitability, heavy free-cash generation and a capital-light expansion plan. At roughly $84 today, shares offer downside protection from low leverage and rising free cash flow, while upside is supported by new-store roll…
Ares Capital (ARCC) yields ~10.3% and trades below book value with a $13.3B market cap. Recent headline risk around private credit has pressured the stock despite manageable portfolio metrics and improving technicals. We upgrade to Buy and recommend initiating a long at $18.50 with a $23.00 target and a $17.25 stop - mid-term (45 trading days) trad…
Pony AI is trading near its 52-week low after a volatile stretch, but recent commercial rollouts (Zagreb), a publicized plan to scale to 3,000 vehicles by year-end, and signs of a sustainable cash burn profile support a mid-term swing trade. I outline an actionable entry at $6.60, a stop at $5.80 and a $9.50 target over the next 45 trading days, wi…
PayPal trades like a broken growth story, but the underlying cash flow, profitability and balance sheet argue it's a value setup. At $45.70 today, the stock is priced at ~8x earnings with $5.5B in free cash flow and a manageable debt load. This trade targets a recovery to $60 over a mid-term (45 trading days) horizon, with a tight $40 stop to keep …
Vor Biopharma (VOR) has moved decisively from an earlier oncology posture into autoimmune disease with telitacicept. Positive Phase 3 signals in China, a string of financings that together exceed $250M, and an enterprise value that still leaves upside if Western registrational data confirm efficacy make VOR a tactical long for risk-tolerant traders…
STAG Industrial ($STAG) looks buyable on a mid-term (45 trading days) basis. The company’s dividend increase, large portfolio scale and technical momentum support a re-rating. Valuation is reasonable at roughly $7.5B market cap with a P/E near 30 and a ~3.9% yield. Enter $39.15, target $44.00, stop $36.00.
